Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.21
SONVY's Cash-to-Debt is ranked lower than
87% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 2.45 vs. SONVY: 0.21 )
Ranked among companies with meaningful Cash-to-Debt only.
SONVY' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.21  Med: 7.83 Max: No Debt
Current: 0.21
Equity-to-Asset 0.50
SONVY's Equity-to-Asset is ranked lower than
64% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. SONVY: 0.50 )
Ranked among companies with meaningful Equity-to-Asset only.
SONVY' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.5  Med: 0.63 Max: 0.7
Current: 0.5
0.5
0.7
Interest Coverage 104.75
SONVY's Interest Coverage is ranked higher than
51% of the 226 Companies
in the Global Medical Devices industry.

( Industry Median: 93.54 vs. SONVY: 104.75 )
Ranked among companies with meaningful Interest Coverage only.
SONVY' s Interest Coverage Range Over the Past 10 Years
Min: 9.86  Med: 40.27 Max: 273.52
Current: 104.75
9.86
273.52
Piotroski F-Score: 5
Altman Z-Score: 8.57
Beneish M-Score: -2.58
WACC vs ROIC
8.65%
18.31%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 18.78
SONVY's Operating Margin % is ranked higher than
90% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. SONVY: 18.78 )
Ranked among companies with meaningful Operating Margin % only.
SONVY' s Operating Margin % Range Over the Past 10 Years
Min: 8.66  Med: 20.09 Max: 27.12
Current: 18.78
8.66
27.12
Net Margin % 15.58
SONVY's Net Margin % is ranked higher than
88% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 1.50 vs. SONVY: 15.58 )
Ranked among companies with meaningful Net Margin % only.
SONVY' s Net Margin % Range Over the Past 10 Years
Min: 6.11  Med: 16.87 Max: 22.75
Current: 15.58
6.11
22.75
ROE % 18.18
SONVY's ROE % is ranked higher than
87% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 2.08 vs. SONVY: 18.18 )
Ranked among companies with meaningful ROE % only.
SONVY' s ROE % Range Over the Past 10 Years
Min: 7.1  Med: 19.56 Max: 31.93
Current: 18.18
7.1
31.93
ROA % 10.99
SONVY's ROA % is ranked higher than
87% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 0.20 vs. SONVY: 10.99 )
Ranked among companies with meaningful ROA % only.
SONVY' s ROA % Range Over the Past 10 Years
Min: 4.42  Med: 12.66 Max: 22.17
Current: 10.99
4.42
22.17
ROC (Joel Greenblatt) % 82.35
SONVY's ROC (Joel Greenblatt) % is ranked higher than
92% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 4.02 vs. SONVY: 82.35 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
SONVY' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 38.49  Med: 94.14 Max: 148.57
Current: 82.35
38.49
148.57
3-Year Revenue Growth Rate 5.30
SONVY's 3-Year Revenue Growth Rate is ranked higher than
54% of the 227 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. SONVY: 5.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
SONVY' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -17.5  Med: 9.7 Max: 21.4
Current: 5.3
-17.5
21.4
3-Year EBITDA Growth Rate 27.60
SONVY's 3-Year EBITDA Growth Rate is ranked higher than
81% of the 199 Companies
in the Global Medical Devices industry.

( Industry Median: 5.60 vs. SONVY: 27.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
SONVY' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -20  Med: 11.2 Max: 48.7
Current: 27.6
-20
48.7
3-Year EPS without NRI Growth Rate 46.00
SONVY's 3-Year EPS without NRI Growth Rate is ranked higher than
86% of the 197 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. SONVY: 46.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
SONVY' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -20.6  Med: 13 Max: 50.6
Current: 46
-20.6
50.6
GuruFocus has detected 1 Warning Sign with Sonova Holding AG $SONVY.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SONVY's 10-Y Financials

Financials (Next Earnings Date: 2017-05-16)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with SONVY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:NYSE:TFX, NAS:ALGN, NYSE:VAR, OTCPK:SDMHF, OTCPK:CNVVY, OTCPK:CHEOY, NAS:ABMD, OTCPK:WILYY, NAS:MASI, OTCPK:SNNUF, OTCPK:FSPKF, NAS:NUVA, OTCPK:EKTAF, OTCPK:GGNDF, NAS:IART, NAS:WMGI, NYSE:NVRO, NYSE:GMED, NYSE:PEN, NAS:LIVN » details
Traded in other countries:PHBN.Germany, SOON.Switzerland, 0QPY.UK,
Sonova Holding AG is engaged in the design, development, manufacture, distribution and service of technologically advanced hearing systems for adults and children with hearing impairment.

Sonova is one of the world's largest manufacturer and distributor of hearing aids. The company is based in Switzerland and distributes its products in more than 90 countries through its internal sales team and independent retailers. It also sells cochlear implants through its Advanced Bionics subsidiary.

Ratios

vs
industry
vs
history
PE Ratio 26.98
SONVY's PE Ratio is ranked higher than
53% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 27.89 vs. SONVY: 26.98 )
Ranked among companies with meaningful PE Ratio only.
SONVY' s PE Ratio Range Over the Past 10 Years
Min: 11.48  Med: 26.57 Max: 77.01
Current: 26.98
11.48
77.01
Forward PE Ratio 20.08
SONVY's Forward PE Ratio is ranked higher than
72% of the 57 Companies
in the Global Medical Devices industry.

( Industry Median: 23.04 vs. SONVY: 20.08 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 26.98
SONVY's PE Ratio without NRI is ranked higher than
53% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 28.39 vs. SONVY: 26.98 )
Ranked among companies with meaningful PE Ratio without NRI only.
SONVY' s PE Ratio without NRI Range Over the Past 10 Years
Min: 11.48  Med: 26.57 Max: 77.01
Current: 26.98
11.48
77.01
Price-to-Owner-Earnings 31.08
SONVY's Price-to-Owner-Earnings is ranked higher than
51% of the 102 Companies
in the Global Medical Devices industry.

( Industry Median: 30.77 vs. SONVY: 31.08 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
SONVY' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 13.15  Med: 28.26 Max: 153.09
Current: 31.08
13.15
153.09
PB Ratio 4.78
SONVY's PB Ratio is ranked lower than
65% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 3.35 vs. SONVY: 4.78 )
Ranked among companies with meaningful PB Ratio only.
SONVY' s PB Ratio Range Over the Past 10 Years
Min: 2.98  Med: 4.88 Max: 10.62
Current: 4.78
2.98
10.62
PS Ratio 4.38
SONVY's PS Ratio is ranked lower than
61% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 3.31 vs. SONVY: 4.38 )
Ranked among companies with meaningful PS Ratio only.
SONVY' s PS Ratio Range Over the Past 10 Years
Min: 2.47  Med: 4.33 Max: 8.02
Current: 4.38
2.47
8.02
Price-to-Free-Cash-Flow 26.23
SONVY's Price-to-Free-Cash-Flow is ranked higher than
59% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 29.73 vs. SONVY: 26.23 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
SONVY' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 12.6  Med: 25.01 Max: 42.97
Current: 26.23
12.6
42.97
Price-to-Operating-Cash-Flow 21.11
SONVY's Price-to-Operating-Cash-Flow is ranked lower than
51% of the 139 Companies
in the Global Medical Devices industry.

( Industry Median: 20.26 vs. SONVY: 21.11 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
SONVY' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.35  Med: 19.86 Max: 31.62
Current: 21.11
10.35
31.62
EV-to-EBIT 24.30
SONVY's EV-to-EBIT is ranked higher than
50% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 23.96 vs. SONVY: 24.30 )
Ranked among companies with meaningful EV-to-EBIT only.
SONVY' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.4  Med: 21.9 Max: 53.1
Current: 24.3
8.4
53.1
EV-to-EBITDA 19.65
SONVY's EV-to-EBITDA is ranked lower than
55% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 17.54 vs. SONVY: 19.65 )
Ranked among companies with meaningful EV-to-EBITDA only.
SONVY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.6  Med: 17.5 Max: 34.8
Current: 19.65
7.6
34.8
PEG Ratio 2.91
SONVY's PEG Ratio is ranked lower than
58% of the 77 Companies
in the Global Medical Devices industry.

( Industry Median: 2.47 vs. SONVY: 2.91 )
Ranked among companies with meaningful PEG Ratio only.
SONVY' s PEG Ratio Range Over the Past 10 Years
Min: 0.27  Med: 2.8 Max: 11.41
Current: 2.91
0.27
11.41
Shiller PE Ratio 32.55
SONVY's Shiller PE Ratio is ranked higher than
74% of the 50 Companies
in the Global Medical Devices industry.

( Industry Median: 54.18 vs. SONVY: 32.55 )
Ranked among companies with meaningful Shiller PE Ratio only.
SONVY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 28.1  Med: 33.37 Max: 42.3
Current: 32.55
28.1
42.3
Current Ratio 0.68
SONVY's Current Ratio is ranked lower than
91% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 2.33 vs. SONVY: 0.68 )
Ranked among companies with meaningful Current Ratio only.
SONVY' s Current Ratio Range Over the Past 10 Years
Min: 0.68  Med: 1.98 Max: 2.64
Current: 0.68
0.68
2.64
Quick Ratio 0.49
SONVY's Quick Ratio is ranked lower than
92% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 1.67 vs. SONVY: 0.49 )
Ranked among companies with meaningful Quick Ratio only.
SONVY' s Quick Ratio Range Over the Past 10 Years
Min: 0.49  Med: 1.56 Max: 2.29
Current: 0.49
0.49
2.29
Days Inventory 131.39
SONVY's Days Inventory is ranked lower than
52% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 125.58 vs. SONVY: 131.39 )
Ranked among companies with meaningful Days Inventory only.
SONVY' s Days Inventory Range Over the Past 10 Years
Min: 98.4  Med: 115.88 Max: 131.39
Current: 131.39
98.4
131.39
Days Sales Outstanding 65.68
SONVY's Days Sales Outstanding is ranked higher than
52% of the 240 Companies
in the Global Medical Devices industry.

( Industry Median: 66.89 vs. SONVY: 65.68 )
Ranked among companies with meaningful Days Sales Outstanding only.
SONVY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 62.48  Med: 70.72 Max: 78.93
Current: 65.68
62.48
78.93
Days Payable 41.83
SONVY's Days Payable is ranked lower than
68% of the 227 Companies
in the Global Medical Devices industry.

( Industry Median: 57.49 vs. SONVY: 41.83 )
Ranked among companies with meaningful Days Payable only.
SONVY' s Days Payable Range Over the Past 10 Years
Min: 40.79  Med: 47.23 Max: 54.12
Current: 41.83
40.79
54.12

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.59
SONVY's Dividend Yield % is ranked higher than
53% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.63 vs. SONVY: 1.59 )
Ranked among companies with meaningful Dividend Yield % only.
SONVY' s Dividend Yield % Range Over the Past 10 Years
Min: 0.73  Med: 1.27 Max: 2
Current: 1.59
0.73
2
Dividend Payout Ratio 0.42
SONVY's Dividend Payout Ratio is ranked higher than
50% of the 119 Companies
in the Global Medical Devices industry.

( Industry Median: 0.40 vs. SONVY: 0.42 )
Ranked among companies with meaningful Dividend Payout Ratio only.
SONVY' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.31  Med: 0.35 Max: 0.73
Current: 0.42
0.31
0.73
3-Year Dividend Growth Rate 19.50
SONVY's 3-Year Dividend Growth Rate is ranked higher than
76% of the 76 Companies
in the Global Medical Devices industry.

( Industry Median: 7.50 vs. SONVY: 19.50 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
SONVY' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 19.5
Current: 19.5
0
19.5
Forward Dividend Yield % 1.59
SONVY's Forward Dividend Yield % is ranked higher than
51% of the 188 Companies
in the Global Medical Devices industry.

( Industry Median: 1.63 vs. SONVY: 1.59 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.59
SONVY's 5-Year Yield-on-Cost % is ranked higher than
72% of the 222 Companies
in the Global Medical Devices industry.

( Industry Median: 1.88 vs. SONVY: 1.59 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SONVY' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.73  Med: 1.27 Max: 2
Current: 1.59
0.73
2
3-Year Average Share Buyback Ratio 0.90
SONVY's 3-Year Average Share Buyback Ratio is ranked higher than
90% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: -3.40 vs. SONVY: 0.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SONVY' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -26.8  Med: -0.45 Max: 0.9
Current: 0.9
-26.8
0.9

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.84
SONVY's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
99.99% of the 127 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. SONVY: 1.84 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
SONVY' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0  Med: 2.01 Max: 5.66
Current: 1.84
0
5.66
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.52
SONVY's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
55% of the 22 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. SONVY: 2.52 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.01
SONVY's Price-to-Median-PS-Value is ranked lower than
99.99% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 1.07 vs. SONVY: 1.01 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SONVY' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0  Med: 0.97 Max: 1.35
Current: 1.01
0
1.35
Price-to-Peter-Lynch-Fair-Value 2.97
SONVY's Price-to-Peter-Lynch-Fair-Value is ranked lower than
99.99% of the 55 Companies
in the Global Medical Devices industry.

( Industry Median: 1.68 vs. SONVY: 2.97 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
SONVY' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0  Med: 1.78 Max: 2.97
Current: 2.97
0
2.97
Earnings Yield (Greenblatt) % 4.12
SONVY's Earnings Yield (Greenblatt) % is ranked higher than
77% of the 339 Companies
in the Global Medical Devices industry.

( Industry Median: -0.81 vs. SONVY: 4.12 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SONVY' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 1.9  Med: 4.6 Max: 11.9
Current: 4.12
1.9
11.9
Forward Rate of Return (Yacktman) % 12.38
SONVY's Forward Rate of Return (Yacktman) % is ranked higher than
60% of the 119 Companies
in the Global Medical Devices industry.

( Industry Median: 9.01 vs. SONVY: 12.38 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
SONVY' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -3  Med: 8.4 Max: 46.4
Current: 12.38
-3
46.4

More Statistics

Revenue (TTM) (Mil) $2,189
EPS (TTM) $ 1.04
Beta0.93
Short Percentage of Float0.00%
52-Week Range $22.70 - 29.45
Shares Outstanding (Mil)326.60

Analyst Estimate

Mar17 Mar18
Revenue (Mil $) 2,364 2,651
EPS ($) 1.12 1.33
EPS without NRI ($) 1.12 1.33
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.07%
Dividends per Share ($) 0.45 0.57

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)